BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ren X, Wei X, Ding Y, Qi F, Zhang Y, Hu X, Qin C, Li X. Comparison of neoadjuvant therapy and upfront surgery in resectable pancreatic cancer: a meta-analysis and systematic review. Onco Targets Ther 2019;12:733-44. [PMID: 30774360 DOI: 10.2147/OTT.S190810] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Bhogal RH, Pericleous S, Khan AZ. Open and Minimal Approaches to Pancreatic Adenocarcinoma. Gastroenterol Res Pract 2020;2020:4162657. [PMID: 32565781 DOI: 10.1155/2020/4162657] [Reference Citation Analysis]
2 Tang R, Meng Q, Wang W, Liang C, Hua J, Xu J, Yu X, Shi S. Head-to-head comparison between FOLFIRINOX and gemcitabine plus nab-paclitaxel in the neoadjuvant chemotherapy of localized pancreatic cancer: a systematic review and meta-analysis. Gland Surg 2021;10:1564-75. [PMID: 34164301 DOI: 10.21037/gs-21-16] [Reference Citation Analysis]
3 Wang D, Liu C, Zhou Y, Yan T, Li C, Yang Q, Xu Y, Zhao L, Pei Q, Tan F, Güngör C, Li Y. Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis. Radiat Oncol 2020;15:107. [PMID: 32404114 DOI: 10.1186/s13014-020-01561-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]